MedTrace Logo

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

NCT02287636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-02-24

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies how well positron emission tomography (PET)/magnetic resonance imaging (MRI) works compared to PET/computed tomography (CT) in diagnosing younger patients with cancer. PET/MRI and PET/CT are procedures that combine the pictures from a PET scan and an MRI scan or a CT scan. The PET and MRI scans or PET and CT scans are done at the same time with the same machine. The combined scans give more detailed pictures of areas inside the body than either scan gives by itself. It is not yet known whether PET/MRI works better than PET/CT in diagnosing younger patients with cancer.

Conditions

  • Childhood Cancer

Interventions

RADIATION

fludeoxyglucose F 18

Undergo fludeoxyglucose F 18 PET/CT

PROCEDURE

positron emission tomography

Undergo fludeoxyglucose F 18 PET/CT

PROCEDURE

computed tomography

Undergo fludeoxyglucose F 18 PET/CT

PROCEDURE

positron emission tomography

Undergo PET/MRI

PROCEDURE

magnetic resonance imaging

Undergo PET/MRI

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Barbara Bangert · Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287636 on ClinicalTrials.gov